MARKET

NCNA

NCNA

Nucana
NASDAQ
0.2600
-0.0467
-15.21%
After Hours: 0.2519 -0.0081 -3.12% 19:41 03/28 EDT
OPEN
0.2350
PREV CLOSE
0.3067
HIGH
0.2752
LOW
0.2345
VOLUME
1.30M
TURNOVER
0
52 WEEK HIGH
0.9989
52 WEEK LOW
0.2263
MARKET CAP
13.74M
P/E (TTM)
-0.3886
1D
5D
1M
3M
1Y
5Y
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. The company reported a wider-than-expected fourth-quarter loss. Avalo Therapeutics, Inc. Shares jumped 430% in today's mid-day session. Other stocks moving in the market include RH, Ggoorks and Xilio.
Benzinga · 21h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Avalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday's regular session. The company's market cap stands at $17.6 million. Biodexa Pharmaceuticals and Ontrak stock increased by 71.82% and 37.66% respectively. Q4 earnings came out today.
Benzinga · 22h ago
Why NuCana (NCNA) Shares Are Trading Lower
NuCana plc shares are trading lower by 15.2% to $0.26. Company says it intends to adjust ratio of its American Depository Shares to its ordinary shares from 1:1 to 1:25. The change is expected to be effective around April 16.
Benzinga · 23h ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, B Riley, Xilio Therapeutics
Wall Street's main stock indexes set to open flat on Thursday in thin trading ahead of Easter break. Dow e-minis up 0.11%, S&P 500 and Nasdaq 100 down 0.02%. Top three NYSE percentage gainers premarket: Cazoo Group, Xilio Therapeutics. Gold miners rise on U.S. Interest rate cut bets. B Riley Financial up 6.7% in premarket.
Reuters · 1d ago
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast. The company's shares jumped 9.4% to $324.99 in pre-market trading. Avalo Therapeutics, Inc. Gained 256.6% on Wednesday.
Benzinga · 1d ago
Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)
Robyn Karnauskas from Truist Financial maintained a Buy rating on Nucana. The company’s shares closed yesterday at $0.31. The firm has a one-year high of $1.00 and a low of $.23. The analyst consensus rating suggests a Moderate Buy.
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. Xilio Therapeutic (XLO) stock moved upwards by 223.94% during the session. Akanda (AKAN) shares increased by 27.1% and INVO Bioscience (INVO) stock increased by 16.36%. NuCana (NCNA) stock declined by 19.8% in the pre- market.
Benzinga · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday. Avalo Therapeutics stock is rocketing more than 268% after announcing a $185 million private placement. Moving stocks this morning are public debuts, earnings reports and more. Ten of the biggest pre-market stocks moving shares this morning.
Investorplace · 1d ago
More
About NCNA
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC-3373 has been evaluated in a Phase I clinical trial for patients with advanced solid tumors and is under Phase Ib/II clinical trial for patients with advanced colorectal cancer. NUC-7738 is a ProTide transformation of a nucleoside analog, 3’-deoxyadenosine (3’-Da). The Company is evaluating NUC-7738 in a Phase I/II clinical trial for patients with advanced solid tumors. Its pipeline also includes Acelari. The Company’s subsidiaries include NuCana, Inc., NuCana Limited and NuCana BioMed Trustee Company Limited.

Webull offers NuCana PLC (ADR) stock information, including NASDAQ: NCNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NCNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NCNA stock methods without spending real money on the virtual paper trading platform.